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ABSTRACT 
Elevated concentrations of ammonia in the brain as a result of hyperammonemia leads to cerebral dysfunction 
involving a spectrum of neuropsychiatric and neurological symptoms (impaired memory, shortened attention span, 
sleep-wake inversions, brain edema, intracranial hypertension, seizures, ataxia and coma). Many studies have 
demonstrated ammonia as a major player involved in the neuropathophysiology associated with liver failure and 
inherited urea cycle enzyme disorders. Ammonia in solution is composed of a gas (NH3) and an ionic (NH4 +) 
component which are both capable of crossing plasma membranes through diffusion, channels and transport 
mechanisms and as a result have a direct effect on pH. Furthermore, NH4 + has similar properties as K+ and, 
therefore, competes with K+ on K+ transporters and channels resulting in a direct effect on membrane potential. 
Ammonia is also a product as well as a substrate for many different biochemical reactions and consequently, an 
increase in brain ammonia accompanies disturbances in cerebral metabolism. These direct effects of elevated 
ammonia concentrations on the brain will lead to a cascade of secondary effects and encephalopathy. 
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INTRODUCTION 
Elevated concentrations of ammonia1 in the brain consequently leads to central nervous system dysfunction and 
encephalopathy. Ammonia accumulates to toxic levels in the brain arising from the blood during hyperammonemic 
conditions as seen in a large number of diseases including liver failure and inborn errors of the urea cycle (Cooper 
and Plum 1987). Ammonia is a metabolite which is mostly produced within the gut during protein digestion and 
deamination. The urea cycle within the liver regulates the concentration of ammonia in the systemic circulation 
maintaining blood ammonia levels in the low 50–100 uM range. Therefore, reduced hepatic capacity for ammonia 
removal leads to hyperammonemia, increased levels of brain ammonia and consequently a spectrum of 
neuropsychiatric and neurological symptoms including impaired memory, shortened attention span, sleep-wake 
inversions, brain edema, intracranial hypertension, seizures, ataxia and coma. During liver failure, brain ammonia 
concentrations can attain 1–5 mM. Many deaths of patients with liver failure occur due to neurological complications 
such as brain edema, increased intracranial pressure and brain stem herniation, which have been demonstrated to 
be related to arterial ammonia concentrations in both clinical (Bernal et al. 2007; Bhatia et al. 2006; Jalan et al. 2004; 
Clemmesen et al. 1999) and animal studies (Sen et al. 2006; Jover et al. 2006; Rose et al. 1999). 
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AMMONIA 
Ammonia is a unique molecule which can act both as a weak base (NH3) or weak acid (NH4 +), has electrolytic 
conductance, and is a product as well as a substrate for many biochemical reactions. Ammonia is composed of a 
gaseous (NH3) and ionic (NH4 +) component, both of which are transportable across phospholipid bilayers (cell 
membranes). This in turn alters intracellular as well as extracellular pH. In aqueous solutions, NH3 is in equilibrium 
with NH4 + (NH3 + H+ ↔ NH4 +) where the ratio of NH3/ NH4 + is a function of pH defined by the Henderson-
Hasselbach equation:  
 
At 37°C the pKa of ammonia is 9.15 (Bromberg et al. 1960), therefore under normal physiological conditions (pH 
7.4), more than 98% of ammonia is present as NH4 +. 
DISTRIBUTION 
Since both the gas (NH3) and the ion (NH4 +) are capable of entering into the cell, this defines ammonia as a complex 
molecule in comparison to other weak acids and bases. 
Ammonia as a gas (NH3) is lipid soluble and therefore enters the brain through diffusion. Interestingly, NH4 + has 
very similar ionic properties to those of K+ with a comparable ionic radius and a similar diffusion coefficient. These 
parallel properties allow NH4 + to compete with K+ on membrane ion channels such as inward rectifying and voltage-
gated K+ channels. Furthermore, NH4 + has been demonstrated to cross cell membranes by substituting K+ in the 
ATPase transporters Na+/K+ and H+/K+ (Moser 1987). In addition, the NH4 +/Cl− and Na+/K+/Cl− cotransporters have 
also demonstrated to transport NH4 + (Aickin et al. 1982; Kelly et al. 2008). 
In addition to ammonia being capable of crossing cell membranes through diffusion as well as through K+ ion 
channels and transporters, there is increasing evidence that a specific ammonia transporter exists in mammals. The 
human nonerythroid Rhesus (Rh) glycoprotein B (RhBG) and C (RhCG) have been identified as mammalian ammonia 
transporters (for review see Bakouh et al. 2006). It has also been demonstrated that ammonia can be transported 
through aquaporin channels, specifically aquaporin-8 (Saparov et al. 2007). However, the regulation as well as the 
specificity (NH3 vs NH4 +) of these transporters still needs to be confirmed. 
CONSEQUENTIAL EFFECTS OF AMMONIA TOXICITY 
Animal models of liver failure develop hyperammonemia and hepatic encephalopathy which are associated with an 
array of biochemical, physiological and molecular changes (Fig. 1). Similar effects are observed when either cultured 
neurons or glia cells are treated with pathophysiological concentrations of ammonia (Sánchez-Pérez and Felipo 
2006; Rama Rao et al. 2003; Chan et al. 2003). For further readings on the effects of ammonia toxicity refer to reviews 
by Felipo and Butterworth (2002) and Cooper and Lai (1987).  
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Fig. 1 Cerebral effects due to ammonia toxicity 
DIRECT EFFECTS OF AMMONIA 
Ammonia has direct effects on cell function which can consequently initiate a cascade of pathophysiological 
pathways as mechanisms as demonstrated in Fig. 1. 
PH 
When ammonia (pH 7.4) is applied to cultured cells (ex. astrocytes), NH3 (<2%) rapidly diffuses across the plasma 
membrane and establishes an equilibrium inside the cell (NH3 + H+ ↔ NH4 +) by combining with cytosolic H+ to form 
NH4 +. Consequently intracellular pH [pH]i increases leading to intracellular alkalinization (Fig. 2). Similar results are 
observed when other weak bases are applied to cultured cell preparations such as trimethylamine (Rose et al. 2005). 
However, the ammonia-induced transient increase in [pH]i recovers towards baseline since NH4 + (>98%) is capable 
of crossing cell membranes (at a slower rate than NH3 diffusion) through different channels and transporters (see 
above). The entry of NH4 + re-establishes a new equilibrium inside the cell (NH3 + H+ ↔ NH4 +), releasing H+ and 
subsequently lowering [pH]i. The amplitude of increased [pH]i (degree of alkalinization) upon ammonia application 
is dependent upon a) the rate of entry of NH3 vs NH4 + into the cell b) the concentration and ratio of NH3 vs NH4 + (pH 
and temperature dependent) and c) the quantitative expression of ammonia “transporters and channels” permitting 
NH4 + to enter the cell. These will also reflect time to recovery of [pH]i and degree of acidification. For example, 
ammonia applied to cultured cells with an over-expression of K+-channels/transporters (or ammonia transporters) 
will result in a smaller amplitude of increased [pH]i and a faster recovery of [pH]i, leading to intracellular 
acidification. Since the ionic component of other weak acids is not capable of crossing cell membranes, the initial 
alkalinization upon application of trimethylamine, does not fully recover. This is supported with experiments by co-
applying barium chloride (a blocker of inwardly-rectifying K+ channels) along with ammonia and observing an initial 
alkalinization followed by a slow recovery to baseline. In conclusion, ammonia due to its similarities with K+, alters 
both intracellular and extracellular pH distinctively from other weak acids and bases.  
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Fig. 2 The effect of ammonia on intracellular pH. Transmembrane fluxes of NH3 exceed fluxes of NH4 + therefore 
resulting in intracellular alkalinization (A). The amplitude of increased [pH]i (degree of alkalinization) as well as 
degree of secondary acidification (B) upon ammonia application is dependent upon the rate of entry and 
concentration of NH3 and NH4 + as well as the quantitative expression of ammonia “transporters and channels” which 
allow NH4 + to enter the cell 
MEMBRANE POTENTIAL 
Since K+ and NH4 + ions are comparable in many aspects, increased concentrations of NH4 + may affect K+ 
homeostasis and therefore compete with K+ on Na+/K+ and H+/K+ ATPase exchangers as well as Na+/K+/Cl− and 
K+/Cl− co-transporters. This in turn may have an impact on the Nernst potential for potassium and resting 
membrane potential. 
High concentrations of ammonia can raise the membrane potential, depolarizing both neurons and astrocytes. It has 
been demonstrated that 2 mM NH4Cl can depolarize hippocampal neurons by approximately 10 mV. An increase in 
positive ions (NH4 +)/positive charge inside the cell depolarizes the membrane potential (Fig. 3a) but not sufficient 
enough to generate an action potential (Fan and Szerb 1993). Astrocytes, who have a lower resting membrane 
potential than neurons, exhibit a concentration-dependent increase in membrane potential following application of 
5, 10 and 20 mM of NH4Cl (Fig. 3b) (Allert et al. 1998). Ammonia (2 mM) added to the superfusate caused a very 
small depolarization (1.6 mV) of the glial cells in a slice of the retina of the honey-bee drone (Coles et al. 1996). 
Activation of the glutamate ionotropic receptor N-methyl-D-aspartate (NMDA) has been demonstrated to play an 
important role in the pathophysiology of hepatic encephalopathy (Llansola et al. 2007). The opening of the channel is 
controlled by a powerful voltage-dependent block by external magnesium ions (Mayer et al. 1984; Nowak et al. 
1984). It is believed ammonia, by raising the membrane potential, removes the magnesium block rendering NMDA 
receptors susceptible to activation. To which degree the magnesium block is removed due to ammonia needs to be 
clarified as it has been demonstrated half the magnesium block is removed upon raising the membrane potential to 
−20 mV (Mayer et al. 1984). In conclusion, pathophysiological concentrations of ammonia directly raise the 
membrane potential in both astrocytes and neurons, however, not sufficiently to activate voltage-gated channels or 
generate an action potential in neurons.  
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Fig. 3 Effect of ammonia on membrane potential in a) neurons (modified from Fan and Szerb 1993) and b) 
astrocytes (modified from Allert et al. 1998) 
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Fig. 4 Direct effects of ammonia consequently lead to secondary effects 
METABOLISM 
Ammonia is an important substrate as well as a product for at least 16 different enzymatic reactions in the brain 
(Cooper and Plum 1987). Increased concentrations of ammonia in the brain results in alterations in metabolism 
affecting regulatory activities of important enzymes such as glutaminase, glutamine synthetase and glutamate 
dehydrogenase. 
SUMMARY 
Ammonia plays a major role in the pathogenesis of hepatic encephalopathy as well as other hyperammonemia-
induced encephalopathies. Ammonia-lowering strategies remain the key therapeutic approach. Ammonia 
neurotoxicity has been demonstrated to be associated with a number of physiological, biochemical and molecular 
changes in the brain. It is the initiating/direct effects of ammonia on cell function which consequentially leads to 
additional secondary effects and stimulates a cascade of pathophysiological pathways leading to cerebral 
dysfunction (Fig. 4). 
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